Vivos Historical Income Statement
| VVOS Stock | USD 2.95 0.06 2.08% |
Historical analysis of Vivos Therapeutics income statement accounts such as Tax Provision of 0.0, Net Interest Income of 0.0, Interest Income of 141.3 K or Depreciation And Amortization of 549.9 K can show how well Vivos Therapeutics performed in making a profits. Evaluating Vivos Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Vivos Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Vivos Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vivos Therapeutics is a good buy for the upcoming year.
Vivos |
About Vivos Income Statement Analysis
Vivos Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Vivos Therapeutics shareholders. The income statement also shows Vivos investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Vivos Therapeutics Income Statement Chart
Add Fundamental
Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Total Revenue
Total revenue comprises all receipts Vivos Therapeutics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Vivos Therapeutics minus its cost of goods sold. It is profit before Vivos Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Operating Income
Operating Income is the amount of profit realized from Vivos Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Vivos Therapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Vivos Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Vivos Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.At this time, Vivos Therapeutics' Interest Income is comparatively stable compared to the past year. Interest Expense is likely to gain to about 1.4 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 549.9 K in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 14K | 1.2M | 1.4M | 1.4M | Depreciation And Amortization | 733K | 669K | 621K | 549.9K |
Vivos Therapeutics income statement Correlations
Click cells to compare fundamentals
Vivos Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.